The Regional Health Contracting Office – Pacific, in support of Tripler Army Medical Center, Hawaii, intends to make a sole source award to Cepheid for the following reagents compatible with the GeneXpert Infinity System molecular analyzers for microbial identification and resistance markers by PCR in patient samples: Xpert C. difficile; Xpert Xpress Strep A; Xpert GBS Lim Broth, IVD; Xpert MRSA, IVD; Xpert  Express EV; Xpert Xpress Flu/RSV; Xpert Xpress SARS CoV-2/Flu/RSV; Xpert Xpress SARS, and lease of analyzer in order to be compliant with prevailing established testing methodology. The contract will be for a 12-month base period plus four 12-month options. The statutory authority permitting this award without providing full and open competition is FAR 13.501(a)(1)(ii) which authorizes the government to award contracts when there is only one responsible source and no other suppliers or services will satisfy agency requirements. The NAICS code is 325413. This announcement fulfills the synopsis requirements under FAR 5.201 and 5.203. This Notice of Intent is not a request for competitive quotes. Information received in response to this notice will be considered solely for the purpose of determining whether a competitive procurement is in the best interest of the Government. All questions and responses concerning this notice shall be emailed to [email protected].

Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to supply the required products. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. No proprietary, classified, confidential, or sensitive information should be included in your response.